EMBC News and Press, Embecta Corp. From 05/12/23

2023-05-12 06:33:26 ET Embecta ( NASDAQ: EMBC ) is collaborating with Tidepool to develop an automated insulin delivery (AID) system for people with type 2 diabetes (T2D). Embecta said it will use the nonprofit organization Tidepool's expertise in diabetes management...

PARSIPPANY, N.J., May 12, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta” or the "Company") (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, today reported financial results for the three- and six-month periods ended March 31, 2023. "Fo...

PARSIPPANY, N.J. and PALO ALTO, Calif., May 12, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, and Tidepool, a 501(c)(3) nonprofit organization committed to harnessing the power of technology to p...

2023-04-22 07:20:00 ET Investing in Dividend Kings is just one part of a solid long-term strategy. The attraction is that their long history of annual dividend increases (50 consecutive years or more) reflects well on the companies' business growth and stability. That doesn't mean that ...

PARSIPPANY, N.J., April 20, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host a conference call to discuss its fiscal second quarter 2023 financial results, provide an operational update, a...

2023-04-12 00:11:00 ET Summary The system is clearly broken, and has been for a while; however, I could find comfort in one thing, my dividends. Four figures in a month is a win in my book. Earning $1,893.81 represents 12.6% year over year increase in passive income. With pati...

2023-03-26 08:45:00 ET Healthcare spinoffs aren't normally seen as companies with strong growth potential. More likely than not, spinoffs stem from a division of a company that, while possibly profitable, is seeing slower growth. Embecta (NASDAQ: EMBC.V) , Viatris (NASDAQ:...

PARSIPPANY, N.J., Feb. 22, 2023 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), one of the largest pure-play diabetes care companies in the world, will host an industry-sponsored symposium at the Advanced Technologies & Treatments for Diabetes (ATTD) international ...

On Tuesday, shares of diabetes management company Embecta (NASDAQ: EMBC.V) managed a more than 12% rise in price. That was due to the impact of its latest set of quarterly results, which trounced analyst estimates for profitability and comfortably topped revenue expectations. Before m...

Embecta Corp. (EMBC) Q1 2023 Earnings Conference Call February 14, 2023 08:00 ET Company Participants Pravesh Khandelwal - Vice President, Investor Relations Dev Kurdikar - Chief Executive Officer Jake Elguicze - Chief Financial Officer Conference Call Participan...